Stenderup, Karin <br/><br/>
Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model.  [electronic resource] 

 -  Acta dermato-venereologica  Nov 2014 
 - 672-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-1838  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Animals<br/>Benzodioxoles--administration & dosage<br/>Dermatologic Agents--administration & dosage<br/>Disease Models, Animal<br/>Female<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Heterografts<br/>Humans<br/>Imidazoles--administration & dosage<br/>Mice, SCID<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Remission Induction<br/>Signal Transduction--drug effects<br/>Skin--drug effects<br/>Skin Transplantation<br/>Time Factors